On March 27, the New York Times published an editorial in support of the FDA's generic drug labeling rule.  CCL Chief Litigaiton Counsel Louis Bograd represented plaintiff Gladys Mensing in the 2011 Supreme Court ruling mentioned in the piece.  You may read the full editorial here.